These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Analysis of various adverse effects of substitute treatment of children with hemophilia]. Adamowicz-Salach A; Głoskowska-Moraczewska Z; Klukowska A; Kamińska D Pediatr Pol; 1988 May; 63(5):326-31. PubMed ID: 2851128 [No Abstract] [Full Text] [Related]
3. [HLA antigens in pemphigus vulgaris and pemphigus foliaceus]. Hashimoto K Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(12):808-9. PubMed ID: 304930 [No Abstract] [Full Text] [Related]
4. Analysis of immune cells in a patient with post-transfusion hepatitis caused by human cytomegalovirus. Asanuma H; Numazaki K; Chiba S In Vivo; 1999; 13(4):339-41. PubMed ID: 10586375 [TBL] [Abstract][Full Text] [Related]
5. [Sporadic superficial pemphigus in the child: 2 cases]. Rybojad M; Ducloy G; Reymond JL; Moraillon I; Flageul B; Vignon-Pennamen MD; Morel P; Bourrat E Ann Dermatol Venereol; 1999 Jan; 126(1):41-3. PubMed ID: 10095891 [TBL] [Abstract][Full Text] [Related]
6. [Pemphigus foliaceus in a child. A two years follow-up under steroid. An immunosuppression therapy (author's transl)]. Larrègue M; Bressieux JM; Bureau B; Gallet P; Rat JP; Pinalie A; de Giacomoni P Ann Dermatol Venereol; 1980 May; 107(5):389-95. PubMed ID: 7224523 [TBL] [Abstract][Full Text] [Related]
7. [Complications in blood transfusion. 2. Infections transmitted by blood and blood products]. Lehmann H Intensivmed Prax; 1982 Jun; 5():93-108. PubMed ID: 6295962 [No Abstract] [Full Text] [Related]
8. HLA-A10 in pemphigus among Japanese. Hashimoto K; Miki Y; Nakata S; Matsuyama M Arch Dermatol; 1977 Nov; 113(11):1518-9. PubMed ID: 931388 [TBL] [Abstract][Full Text] [Related]
9. Postpartum cytomegalovirus infection. A hazard of multiple transfusions. Bryan CS; Foster CM; Edwards WG Obstet Gynecol; 1978 Jul; 52(1 Suppl):68S-69S. PubMed ID: 210434 [TBL] [Abstract][Full Text] [Related]
10. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients. Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346 [TBL] [Abstract][Full Text] [Related]
11. Anti-desmoglein 1 antibodies in healthy related and unrelated subjects and patients with pemphigus foliaceus in endemic and non-endemic areas from Tunisia. Abida O; Kallel-Sellami M; Joly P; Ben Ayed M; Zitouni M; Masmoudi A; Mokni M; Fezzaa B; Ben Osman A; Kammoun MR; Gilbert D; Turki H; Tron F; Masmoudi H; Makni S; J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1073-8. PubMed ID: 19453789 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Chakrabarti S; Pradhan P; Roy A; Hira M; Bandyopadhyay G; Bhattacharya DK Indian J Public Health; 2006; 50(1):43-4. PubMed ID: 17193761 [TBL] [Abstract][Full Text] [Related]
13. Successful anti-CD20 antibody treatment of pemphigus foliaceus after unrelated cord blood transplantation. Herr AL; Hatami A; Kokta V; Dalle JH; Champagne MA; Duval M Bone Marrow Transplant; 2005 Feb; 35(4):427-8. PubMed ID: 15640817 [No Abstract] [Full Text] [Related]